Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Airway Management is a medical device company specializing in the treatment of sleep-disordered breathing, specifically obstructive sleep apnea and snoring. The company is best known for the Thornton Adjustable Positioner (TAP) line of oral appliances, which are custom-mandibular advancement devices designed to keep the airway open during sleep. Their product portfolio includes various iterations of the TAP device, such as the TAP 3, dreamTAP, and myTAP, as well as the Thornton Precision Alignment (TPA) system. Airway Management focuses on providing adjustable, clinician-controlled solutions that offer high patient compliance and clinical efficacy. The company serves dentists and sleep specialists globally through a network of licensed laboratories. With over 50 peer-reviewed studies, the TAP is one of the most clinically validated oral appliances on the market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TAP Sleep Care.